Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 8 min 15 sec ago

Aldea Pharmaceuticals Closes $24 Million Series B Financing

Mon, 08/25/2014 - 12:43
REDWOOD CITY, Calif., Aug. 25, 2014 -- (Healthcare Sales & Marketing Network) -- Aldea Pharmaceuticals, a company pioneering novel therapeutics to treat aldehyde metabolism disorders, today announced that it has closed a $24 million Series B equity financ...
Biopharmaceuticals, Venture Capital
Aldea Pharmaceuticals

Covidien Acquires Reverse Medical Corporation

Fri, 08/22/2014 - 15:07
Generates Opportunity to Leverage Existing Vascular Technologies and Customer Relationships to Drive Increased Market Penetration DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien plc (COV) today announced it has acquired Reverse Medica...
Devices, Mergers & Acquisitions
Covidien, Reverse Medical, ReVerse Microcatheter

Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer

Thu, 08/21/2014 - 13:14
PORTLAND, Ore., Aug. 21, 2014 -- (Healthcare Sales & Marketing Network) -- Galena Biopharma, Inc. (GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major medical needs across the full s...
Biopharmaceuticals, Oncology, Personnel
Galena Biopharma, NeuVax, nelipepimut-S

FDA Approves Changes to Manufacturing Process for Covidien’s Pipeline(TM) Embolization Device

Thu, 08/21/2014 - 13:11
DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien plc (COV) today announced that the U.S. Food and Drug Administration (FDA) has approved changes to the manufacturing process for the polytetrafluoroethylene (PTFE) coating on the delivery wi...
Devices, Interventional, FDA
Covidien, Pipeline embolization, Alligator

Direct Flow Medical(R), Inc. Receives CE Mark for 23mm Valve and for Implantation of All Sizes of Its Transcatheter Aortic Heart Valve Without Use of Contrast

Thu, 08/21/2014 - 13:05
SANTA ROSA, Calif.--(Healthcare Sales & Marketing Network)--Direct Flow Medical®, Inc., a transcatheter heart valve innovator focused on improving patient outcomes, today announced it has received the CE Mark (Conformité Européenne) for a...
Devices, Interventional Cardiology, Regulatory
Direct Flow Medical, Transcatheter Aortic Valve

Advanced Catheter Therapies Announces Series B Equity Financing

Wed, 08/20/2014 - 12:31
CHATTANOOGA, TN--(Healthcare Sales & Marketing Network) - Advanced Catheter Therapies, Inc. (ACT) ( announced today that its $3 million Series B preferred equity financing has been oversubscribed and the company is expanding the round to ...
Devices, Venture Capital
Advanced Catheter Therapies

Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012

Wed, 08/20/2014 - 12:26
Migalastat Successfully Meets Both Co-Primary Endpoints of Comparability to Enzyme Replacement Therapy (ERT) on Both Key Measures of Kidney Function Comparability to ERT Also Demonstrated in Important Fabry Disease Biomarker, Plasma Lyso-Gb3 Proceed...
Amicus Therapeutics, migalastat, Fabry disease

Dermira Completes $51 Million Financing and Expands Management Team and Board of Directors

Tue, 08/19/2014 - 15:15
REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--Dermira, a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products to dermatologists and their patients, today announced that it has co...
Biopharmaceuticals, Dermatology, Venture Capital, Personnel

Aqua Pharmaceuticals, LLC Welcomes Nathan Mitchell as Senior Director, Marketing

Tue, 08/19/2014 - 15:12
WEST CHESTER, Pa.--(Healthcare Sales & Marketing Network)--West Chester-based Aqua Pharmaceuticals, an Almirall company, today announces the addition of Nathan Mitchell as Senior Director, Marketing. In this role, Mitchell will be responsible for strategiz...
Biopharmaceuticals, Dermatology, Personnel
Aqua Pharmaceuticals, Almirall

FDA Approves Use of AFLURIA(R) Influenza Vaccine with PharmaJet’s Needle-Free Injector

Tue, 08/19/2014 - 14:40
Jet injector device delivers single dose of injectable flu vaccine without a needle KING OF PRUSSIA, Pa. & GOLDEN, Colo.--(Healthcare Sales & Marketing Network)--PharmaJet® Inc., the developer of a needle-free injection technology to administer medi...
Biopharmaceuticals, Drug Delivery, FDA
PharmaJet, bioCSL , AFLURIA, Influenza Vaccine

Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs

Tue, 08/19/2014 - 14:26
Companies Reach Agreement to Develop a New and Differentiated FFR Guidewire and Next Generation Boston Scientific Rotablator™ RotaWire™ MARLBOROUGH, Mass. and NAGOYA, Japan, Aug. 19, 2014 -- (Healthcare Sales & Marketing Network) -- Boston Scientific C...
Devices, Interventional Cardiology
Boston Scientific, ASAHI INTECC, fractional flow reserve, FFR wires

Rosetta Genomics Expands Management Team With Appointment of Douglas Sites as Executive Vice President of Sales and Marketing

Mon, 08/18/2014 - 13:32
Brings Extensive Track Record in Leading Commercial Teams and Driving Revenues in MicroRNA, Oncology and Thyroid Diagnostics PRINCETON, NJ and REHOVOT, ISRAEL--(Healthcare Sales & Marketing Network) - Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading deve...
Diagnostics, Personnel
Rosetta Genomics

Mark S. Levine Joins Minerva Neurosciences as VP and General Counsel

Mon, 08/18/2014 - 13:28
CAMBRIDGE, Mass., Aug. 18, 2014 -- (Healthcare Sales & Marketing Network) -- Minerva Neurosciences (NERV), a leader in the development of new therapies to treat neuropsychiatric diseases and disorders, today announced that Mark S. Levine has been appointe...
Biopharmaceuticals, Neurology, Personnel
Minerva Neurosciences

ResMed's New AirSense 10 CPAP and APAP Devices Deliver Superior Patient Comfort and Cost-Saving Efficiency for Healthcare Providers

Mon, 08/18/2014 - 13:23
Intelligent AirSense 10 Flow Generators Promote Precise, Personalized Patient Care SAN DIEGO, Aug. 18, 2014 -- (Healthcare Sales & Marketing Network) -- ResMed (RMD), the industry leader in patient-comfort innovation, today introduced its new AirSense...
ResMed, AirSense, positive-airway pressure

Ampio Announces Very Positive Results of the Open Label Portion of the Multiple Intra-articular Injections Study of Ampion(TM) in Patients with Osteoarthritis of the Knee at Week Six of the Trial

Mon, 08/18/2014 - 13:18
ENGLEWOOD, Colo., Aug. 18, 2014 -- (Healthcare Sales & Marketing Network) -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced the 6 weeks results of the open label portion of the multiple injections of Ampion™ into the knees of patients (n=7) ...
Biopharmaceuticals, Orthopaedic
Ampio Pharmaceuticals, Ampion , osteoarthritis

Boston Therapeutics Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. to Its Medical Advisory Board

Mon, 08/18/2014 - 13:11
MANCHESTER, NH--(Healthcare Sales & Marketing Network) - Boston Therapeutics, Inc. (OTCQB: BTHE), a developer of complex carbohydrate therapeutics to treat diabetes, has appointed noted diabetes specialist Jaime A. Davidson, M.D. to its Medical Advisory Bo...
Biopharmaceuticals, Endocrinology, Personnel
Boston Therapeutics

Cook Medical Enrolls First Patient in Zilver(R) PTX(R) Drug Eluting Peripheral Stent Clinical Study in China

Fri, 08/15/2014 - 12:54
BLOOMINGTON, Ind.--(Healthcare Sales & Marketing Network)--Cook Medical has enrolled the first patient in the clinical study in China of its Zilver® PTX® Drug Eluting Peripheral Stent. The case was performed by one of the study’s principal investig...
Devices, Interventional
Cook Medical, Zilver PTX, drug eluting stent, peripheral artery disease

Innovus Pharma and Consortia Health Initiate a Nationwide Marketing and Sales Campaign to U.S. Gynecologists for Zestra(R), Clinically Proven for the Enhancement of Female Arousal Desire and Satisfaction

Fri, 08/15/2014 - 12:48
SAN DIEGO, Aug. 15, 2014 -- (Healthcare Sales & Marketing Network) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) (INNV) a leader in over-the-counter ("OTC") and consumer care products fo...
Innovus Pharmaceuticals, Consortia Health, Zestra

FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer

Thu, 08/14/2014 - 21:19
Avastin is the first biologic medicine approved in combination with chemotherapy to help women with this type of cancer live longer than with chemotherapy alone SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Genentech, a member of ...
Biopharmaceuticals, Oncology, FDA
Genentech, Roche Group, Avastin, bevacizumab, Cervical Cancer

Vermillion Announces Additions to Commercial Management Team

Thu, 08/14/2014 - 13:33
AUSTIN, Texas, Aug. 14, 2014 -- (Healthcare Sales & Marketing Network) -- Vermillion, Inc. (VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has appointed David Jansen as Vice President of Marketing. In addition...
Diagnostics, Personnel

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong